{"nct_id":"NCT03086343","title":"A Phase 3 Study to Compare Upadacitinib to Abatacept in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease- Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDs","status":"COMPLETED","status_verified_date":"2024-07","start_date":"2017-05-09","start_date_type":"ACTUAL","primary_completion_date":"2019-06-13","primary_completion_date_type":"ACTUAL","completion_date":"2023-06-06","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["ABBV"]}